Company intelligence / Profile preview

Mannitab Pharma Specialities

Malegaon, Maharashtra, India
Ownership
Private
Development stage
Other
01

Overview

Mannitab Pharma Specialities manufactures specialty mannitol grades for direct compression and other pharmaceutical excipient uses. Acquired majority by Ingredion, it serves pharmaceutical and nutraceutical customers requiring excipient solutions in high-value drug formulations. No evidence of clinical programs; business is focused on ingredient manufacturing for pharma production[1][2].

Modalities
ExcipientSmall molecule
Industry
Chemicals & Materials
02

Partnerships

M.B. Sugars & Pharmaceuticals Private LimitedIngredion

Beyond the preview

Go deeper on Mannitab Pharma Specialities.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mannitab Pharma Specialities.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call